UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 22, 2006
COMBINATORX, INCORPORATED
(Exact name of Registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
000-51171 |
| 04-3514457 |
(Commission File No.) |
| (IRS Employer Identification No.) |
245 First Street
Sixteenth Floor
Cambridge, MA 02142
(Address of principal executive offices and zip code)
Registrant’s telephone number, including area code: (617) 301-7000
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
On June 22, 2006, CombinatoRx, Incorporated issued a press release announcing additional results of its phase 2 clinical trial of CRx-102 in patients with osteoarthritis (OA) of the hand. The full text of CombinatoRx’s press release regarding the announcement is filed as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(c) Exhibits
Exhibit No. |
| Description |
99.1 |
| Press release of CombinatoRx, Incorporated dated June 22, 2006. |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
| ||
| COMBINATORX, INCORPORATED | |||
|
|
| ||
|
|
| ||
|
| By: |
| /s/ Jason F. Cole |
|
| Name: |
| Jason F. Cole |
|
| Title: |
| Senior Vice President and |
|
|
|
| General Counsel |
Dated: June 22, 2006
Exhibit No. |
| Description |
99.1 |
| Press release of CombinatoRx, Incorporated dated June 22, 2006. |